WALTHAM, Mass., Sept. 1, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today that it will present at Baird’s 2011 Health Care Conference on Thursday, September 8, 2011, at 12:45 p.m. Eastern Time. Pieter Muntendam, MD, President and CEO of the Company, will participate in a corporate presentation that will include highlights of galectin-3 studies recently presented at the European Society of Cardiology (ESC) Congress 2011. The presentation will be available to the public through a webcast accessible by visiting: http://www.wsw.com/webcast/baird24/bgmd/ or the “Investors” section of the Company’s website at www.bg-medicine.com. Replays will be available for 30 days after the presentation.
